← Leaderboards
Nicholas Mitsiades
Baylor College Of Medicine
$4,650,814
Attributed
$4,650,814
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2015–22$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,261,998 · 5
By mechanism
U54$3,460,031 · 4
R01$1,801,967 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- James P Orengo$2,603,782
- Susan M Blaney$10,519,074
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularInnovationMalignant NeoplasmsDesignSignal TransductionResistanceBaseCombinatorialReportingChemotherapyCollegePropertyCollaborationsProteinsOncogenicMinorityPathway InteractionsHealth DisparityMedicineCancer CenterCancer Health DisparityNovel TherapeuticsGenetic TranscriptionPharmaceutical Preparations
Grant awards (11)
THE RNA HELICASE EIF4A IS A THERAPEUTIC VULNERABILITY IN TRIPLE-NEGATIVE BREAST CANCER$200,000
U54 · FY2022 · CA · contact PI
Combating Highly Aggressive Prostate Cancer: Development of Novel Patient Derived Xenograft Models and Application in Preclinical Studies of Novel Selective Androgen Receptor Degraders$120,000
U54 · FY2021 · CA · contact PI
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF$351,691
R01 · FY2019 · CA · contact PI
Minority PDX Development and Trial Center: Baylor College of Medicine and MD Anderson Cancer Center Collaboration on Mechanistic Studies to Dissect and Combat Health Disparities in Cancer$291,184
U54 · FY2019 · CA · contact PI
RP1: Combating Racial Health Disparities in PC: Building Mechanism-Driven Rationale for Single and Combinatorial Therapies Against Overactive Kinase Signaling and DDR using AA PDXs$1,939,255
U54 · FY2018 · CA · contact PI
Pilot Projects and Trans-Network Activities Core$768,186
U54 · FY2018 · CA · contact PI
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF$362,569
R01 · FY2018 · CA · contact PI
Administrative Core$141,406
U54 · FY2018 · CA · contact PI
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF$362,569
R01 · FY2017 · CA · contact PI
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF$362,569
R01 · FY2016 · CA · contact PI
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF$362,569
R01 · FY2015 · CA · contact PI